The Taiwan Food and Drug Administration (TFDA) has received a new drug application for CStone Pharmaceuticals' (HKEX: 2616) TIBSOVO (ivosidenib) through a third-party as a first to-be-approved treatment of adult patients with relapsed or refractory acute myeloid leukaemia
(R/R AML) with a susceptible IDH1 mutation, it was reported yesterday.
KEYWORDS: Acute myeloid leukaemia
, Complete response (CR), Disease free survival (DFS), FLT-3 ITD, NPM-1.
Background: Chronic myeloid leukaemia
(CML) is myeloproliferative disorder.
Jeff died, aged 73, on August 16, 2017, after a brave battle with acute myeloid leukaemia
At this point in time, however there is lack of availability of validated instruments to measure patients' quality of life in CML We developed a questionnaire to record patient reported adverse effects and quality of life issues for chronic myeloid leukaemia
BerGenBio ASA announces that the company and its collaborators will present interim clinical data from its Phase II clinical development programme with bemcentinib, a selective, oral AXL inhibitor, in acute myeloid leukaemia
(AML) and myeloid dysplastic syndrome (MDS) at the 23rd Congress of the European Hematology Association (EHA) in Stockholm (14-17 June 2018).
Gemma died in November, three days after being diagnosed with acute myeloid leukaemia
Bauters, "Cytogenetics and their prognostic value in de novo acute myeloid leukaemia
: a report on 283 cases," British Journal of Haematology, vol.
Rosti et al., "Chronic myeloid leukaemia
: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up," Annals of Oncology, vol.
Objective: To analyse a decade-long pattern of clinical presentation of acute myeloid leukaemia
patients and compare it with contemporary data.
Clonal evolution in relapsed acute myeloid leukaemia
revealed by whole genome sequencing.
AN expert multi-disciplinary team from the National Center for Cancer Care and Research (NCCCR), a member of Hamad Medical Corporation (HMC), has performed Qatar's first allogeneic haematopoietic stem cell transplantation (allogeneic-HSCT) on a 32-year-old female patient diagnosed with acute myeloid leukaemia
, an aggressive form of blood cancer.